Ritolukast

DB19517ExperimentalSmall molecule

Ritolukast is a small molecule drug. The usage of the INN stem '-lukast' in the name indicates that Ritolukast is a leukotriene receptor antagonist. Ritolukast has a monoisotopic molecular weight...

Mechanism: Pharmacologically active on Cysteinyl leukotriene receptor 1
Curator reviewed
Formula / weight: C₁₇H₁₃F₃N₂O₃S · 382.36 g/mol (avg)
Code names: WY-48252

Resolves to

Compound

UNII0E8R4GDE2QCAS111974-60-8ChEMBLCHEMBL17344ChEBI747996PubChem60539

Structure

InChIKeyGOHUJGMYCZDYDF-UHFFFAOYSA-NSMILESFC(F)(F)S(=O)(=O)NC1=CC(OCC2=NC3=CC=CC=C3C=C2)=CC=C1

Targets

Q9Y271CYSLTR1

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Ritolukast, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account